Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Accurate diagnosis and management of rare genian fistulas require combined clinical, radiologic, and histopathologic evaluations.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

Four new FGF5 gene variants cause long hair in dogs.

Adding a cosmetic gel with caffeine, taurine, and growth factors to standard hair loss treatments could improve results.

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Microneedling with CGF significantly improves hair regrowth in androgenetic alopecia.

Sweat glands and hair follicles are structurally connected within a specific layer of skin fat.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

More inflammation leads to faster and worse hair loss in women with frontal fibrosing alopecia.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

FFA's causes may include environmental triggers and genetic factors.

GLI2 increases follistatin production in human skin cells.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Epidermal growth factor slows hair and body growth in mice.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.